Neovasc Inc is a medical devices business based in the US. Neovasc shares (NVCN) are listed on the NASDAQ and all prices are listed in US Dollars. Neovasc employs 71 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Neovasc
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NVCN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Neovasc stock price (NASDAQ: NVCN)Use our graph to track the performance of NVCN stocks over time.
Neovasc shares at a glance
|Latest market close||$0.91|
|52-week range||$0.70 - $2.85|
|50-day moving average||$0.90|
|200-day moving average||$1.10|
|Wall St. target price||$1.88|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-5.64|
Buy Neovasc shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Neovasc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Neovasc price performance over time
|1 week (2021-07-18)||N/A|
|1 month (2021-06-29)||0.91|
|3 months (2021-04-29)||-6.19%|
|6 months (2021-01-25)||N/A|
|1 year (2020-07-25)||N/A|
|2 years (2019-07-25)||N/A|
|3 years (2018-07-25)||N/A|
|5 years (2016-07-25)||N/A|
|Revenue TTM||$1.9 million|
|Gross profit TTM||$1.5 million|
|Return on assets TTM||-46.55%|
|Return on equity TTM||-82.81%|
|Market capitalisation||$54.5 million|
TTM: trailing 12 months
Shorting Neovasc shares
There are currently 1.4 million Neovasc shares held short by investors – that's known as Neovasc's "short interest". This figure is 13% down from 1.6 million last month.
There are a few different ways that this level of interest in shorting Neovasc shares can be evaluated.
Neovasc's "short interest ratio" (SIR)
Neovasc's "short interest ratio" (SIR) is the quantity of Neovasc shares currently shorted divided by the average quantity of Neovasc shares traded daily (recently around 1.2 million). Neovasc's SIR currently stands at 1.15. In other words for every 100,000 Neovasc shares traded daily on the market, roughly 1150 shares are currently held short.
However Neovasc's short interest can also be evaluated against the total number of Neovasc shares, or, against the total number of tradable Neovasc shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Neovasc's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Neovasc shares in existence, roughly 20 shares are currently held short) or 0.0253% of the tradable shares (for every 100,000 tradable Neovasc shares, roughly 25 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Neovasc.
Find out more about how you can short Neovasc stock.
Neovasc share dividends
We're not expecting Neovasc to pay a dividend over the next 12 months.
Have Neovasc's shares ever split?
Neovasc's shares were split on a 1:10 basis on 1 July 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Neovasc shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Neovasc shares which in turn could have impacted Neovasc's share price.
Neovasc share price volatility
Over the last 12 months, Neovasc's shares have ranged in value from as little as $0.7 up to $2.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neovasc's is 2.925. This would suggest that Neovasc's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Neovasc Inc. , a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc.
Stocks similar to Neovasc
Neovasc in the news
Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
Neovasc Announces New Appointments in Regulatory and Clinical Leadership
Frequently asked questionsWhat percentage of Neovasc is owned by insiders or institutions?
Currently 48.638% of Neovasc shares are held by insiders and 32.458% by institutions. How many people work for Neovasc?
Latest data suggests 71 work at Neovasc. When does the fiscal year end for Neovasc?
Neovasc's fiscal year ends in December. Where is Neovasc based?
Neovasc's address is: 13562 Maycrest Way, Richmond, BC, Canada, V6V 2J7 What is Neovasc's ISIN number?
Neovasc's international securities identification number is: CA64065J3047 What is Neovasc's CUSIP number?
Neovasc's Committee on Uniform Securities Identification Procedures number is: 64065J106
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert